SHG · Healthcare

Shanghai Hile Bio-tech (603718)

Biotechnology

Shanghai Hile Bio-tech (603718) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 603718

P/E ratio
25.00

Shanghai Hile Bio-tech (603718) — FAQ

What is 603718's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Hile Bio-tech (603718) is 25.00 (data as of 2026-05-23).

Does Shanghai Hile Bio-tech pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Hile Bio-tech (603718). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Hile Bio-tech in?

Shanghai Hile Bio-tech (603718) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 603718 listed on?

603718 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play